Literature DB >> 9344553

Chiasmatic specificity in the regenerating mammalian optic nerve.

R E MacLaren1, J S Taylor.   

Abstract

The mammalian central nervous system is capable of regenerating; however, there is no evidence that the regenerating axons can navigate along their normal pathways and reestablish topographically organized projections: essential for functional return of vision. Here retinal ganglion cells in the opossum Monodelphis were birthdated with tritiated thymidine on the sixth postnatal day (P6), before being lesioned in the temporal retina at P8. Retrograde tracing with horseradish peroxidase injected into the ipsilateral optic tract at P24 showed that the temporal crescent had reformed behind the retinal lesion. By comparisons of cell and thymidine counts from lesioned and control regions of retina, it was estimated that about 40% of the normal number of ganglion cells are able to regenerate into the ipsilateral optic tract following a lesion in the temporal retina at P8. A clear line of decussation (separation of ipsilateral and contralateral projections) reformed in the lesioned temporal retina and regenerating ganglion cells labeled with DiI were turned at appropriate points on passing through the optic chiasm. This is evidence of chiasmatic specificity with regard to lesioned retinal ganglion cells regenerating into the ipsilateral optic tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344553     DOI: 10.1006/exnr.1997.6620

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  4 in total

Review 1.  Factors secreted by Schwann cells stimulate the regeneration of neonatal retinal ganglion cells.

Authors:  Jeremy S H Taylor; Edward T W Bampton
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

Review 2.  Regeneration and transplantation of the optic nerve: developing a clinical strategy.

Authors:  R E MacLaren
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 3.  Promises of stem cell therapy for retinal degenerative diseases.

Authors:  Ian Yat-Hin Wong; Ming-Wai Poon; Rosita Tsz-Wai Pang; Qizhou Lian; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-25       Impact factor: 3.117

Review 4.  Induced pluripotent stem cell therapies for retinal disease.

Authors:  Oliver Comyn; Edward Lee; Robert E MacLaren
Journal:  Curr Opin Neurol       Date:  2010-02       Impact factor: 5.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.